HRQOL implications of treatment with dexamethasone for children with acute lymphoblastic leukemia (ALL)

Pediatric Blood and Cancer

Volumn 46, Issue 1, 2006, Pages 35-39

  Eiser, Christine ^a   Davies, Helena ^b   Jenney, Meriel ^c   Stride, Chris ^a   Glaser, Adam ^d  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^c LLANDOUGH HOSPITAL   (United Kingdom)

^d ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

ALL; Dexamethasone; HRQOL; Prednisone

Indexed keywords

DEXAMETHASONE; PREDNISONE; STEROID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROPSYCHOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

EID: 28844478545     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20432     Document Type: Article

References (15)

1. Stiller CA, Eatock EM. Patterns of care and survival for children with acute lymphoblastic leukemia diagnosed between 1980-1994. Arch Dis Child 1999;81:202-208.
2. Hawkins MM, Stevens MCG. The long term survivors. BMJ 1996;52:898-923.
3. Craft AW. Childhood cancer-Mainly curable so where next? Acta Paediatrica 2000;89:386-392.
4. Stiefel FC, Breibert WS, Holland JC, Corticosteroids in cancer: Neuropsychiatric complications. Cancer Invest 1989;7:479-491.
5. Drigan R, Spirito A, Gelber RD. Behavioral effects of corticosteroids in children with acute lymphoblastic leukemia. Med Pediatr Oncol 1992;20:13-21.
6. Veerman AJ, Hahlen K, Kamps WA, et al. High cure rate with moderately intensive treatment regimen in a non high-risk childhood acute lymphoblastic leukemia: Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group. J Clin Oncol 1996;14:911-918.
7. Jones B, Freeman AI, Shuster JJ, et al. Lower incidence of meningeal leukemia when prednisone is replaced in the treatment of acute lymphocytic leukemia. Med Pediatr Oncol 1991;19:269-275.
8. Bostrom BC, Sensel MR, Sather HN, et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard risk acute lymphoblastic leukemia. Blood 2003;101:3809-3817.
9. Waber DP, Carpentieri SC, Klar N, et al. Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethosone or prednisolone. J Pediatr Hematol/Oncol 2000;22:206-213.
10. Eiser C. Children with cancer: Quality of life. New Jersey: Lawrence Erlbaum; 2004.
11. Varni JW, Seid M, Kurtin PS. PedsQL 4.0: Reliability and validity of the pediatric quality of life inventory version 4.0 Generic core scales in healthy and patient populations. Med Care 2001;39:800-812.
12. Ware JE, Snow KK, Kosinski M, et al. SF-36 health survey manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center; 1993.
13. Eiser C, Eiser JR, Mayhew AG, et al. Parenting the premature infant: Balancing vulnerability and quality of life. J Child Psychol Psychiatr (in press).
14. Jenkinson C, Coulter A, Wright L. Short form 36 (SF-36) health survey questionnaire: Normative data for adults of working age. BMJ 1993;306:1437-1440.
15. Eiser C, Morse R. Quality of life measures in chronic diseases of childhood. Health Technol Assess 2001;5:1-156.